Version history

{
  "description": "Pathogenic gut bacteria prime peripheral macrophages through NLRP3 inflammasome activation, creating a systemic pro-inflammatory state that enhances neuroinflammation and dopaminergic neuron vulnerability. Selective inflammasome inhibitors combined with microbiome restoration could break this inflammatory cycle.",
  "target_gene": "NLRP3, CASP1, IL1B, PYCARD",
  "target_pathway": "NLRP3 inflammasome activation",
  "disease": "neurodegeneration",
  "hypothesis_type": "mechanistic",
  "status": "proposed",
  "confidence_score": 0.9,
  "novelty_score": 0.7,
  "feasibility_score": 0.8,
  "impact_score": 0.8,
  "composite_score": 0.653,
  "mechanistic_plausibility_score": 0.8,
  "druggability_score": 0.9,
  "safety_profile_score": 0.6,
  "evidence_for": [
    {
      "doi": "10.1038/s41423-025-01275-w",
      "url": "https://pubmed.ncbi.nlm.nih.gov/40075143/",
      "pmid": "40075143",
      "year": "2025",
      "claim": "NLRP3 inflammasome in neuroinflammation and central nervous system diseases.",
      "caveat": "Search-derived citation; verify claim-level fit before promotion.",
      "source": "Cell Mol Immunol",
      "strength": "medium"
    },
    {
      "doi": "10.1016/j.xcrm.2024.101522",
      "url": "https://pubmed.ncbi.nlm.nih.gov/38701781/",
      "pmid": "38701781",
      "year": "2024",
      "claim": "Microglial CMPK2 promotes neuroinflammation and brain injury after ischemic stroke.",
      "caveat": "Search-derived citation; verify claim-level fit before promotion.",
      "source": "Cell Rep Med",
      "strength": "medium"
    },
    {
      "doi": "10.1073/pnas.2011226118",
      "url": "https://pubmed.ncbi.nlm.nih.gov/34497121/",
      "pmid": "34497121",
      "year": "2021",
      "claim": "NAD(+) supplementation reduces neuroinflammation and cell senescence in a transgenic mouse model of Alzheimer's disease via cGAS-STING.",
      "caveat": "Search-derived citation; verify claim-level fit before promotion.",
      "source": "Proc Natl Acad Sci U S A",
      "strength": "medium"
    },
    {
      "doi": "10.1186/s12974-023-02744-7",
      "url": "https://pubmed.ncbi.nlm.nih.gov/36859349/",
      "pmid": "36859349",
      "year": "2023",
      "claim": "Berberine ameliorates depression-like behaviors in mice via inhibiting NLRP3 inflammasome-mediated neuroinflammation and preventing neuroplasticity disruption.",
      "caveat": "Search-derived citation; verify claim-level fit before promotion.",
      "source": "J Neuroinflammation",
      "strength": "medium"
    },
    {
      "doi": "10.3389/fimmu.2021.714943",
      "url": "https://pubmed.ncbi.nlm.nih.gov/34367186/",
      "pmid": "34367186",
      "year": "2021",
      "claim": "Janus Kinase Inhibition Ameliorates Ischemic Stroke Injury and Neuroinflammation Through Reducing NLRP3 Inflammasome Activation via JAK2/STAT3 Pathway Inhibition.",
      "caveat": "Search-derived citation; verify claim-level fit before promotion.",
      "source": "Front Immunol",
      "strength": "medium"
    }
  ],
  "evidence_against": [
    {
      "url": "https://pubmed.ncbi.nlm.nih.gov/34117094/",
      "pmid": "34117094",
      "year": "2021",
      "claim": "MCC950/NLRP3 inhibition has strong preclinical rationale but translational pharmacology and safety limitations remain unresolved for chronic neurodegenerative use.",
      "title": "Pharmacological Inhibition of the Nod-Like Receptor Family Pyrin Domain Containing 3 Inflammasome with MCC950.",
      "caveat": "Counter-evidence curated for task 9df1f940-93f3-4f2f-9a72-89e8f93d2276; verify claim-level fit before promotion.",
      "source": "Pharmacol Rev",
      "strength": "medium",
      "evidence_type": "counter_evidence"
    },
    {
      "url": "https://pubmed.ncbi.nlm.nih.gov/40792655/",
      "pmid": "40792655",
      "year": "2025",
      "claim": "A Parkinson NLRP3 inhibitor study focused on anti-inflammatory biomarker effects rather than demonstrated disease modification, leaving the clinical impact of inflammasome blockade uncertain.",
      "title": "Anti-Neuroinflammatory and Anti-Inflammatory Effects of the NLRP3 Inhibitor NT-0796 in Subjects with Parkinson's Disease.",
      "caveat": "Counter-evidence curated for task 9df1f940-93f3-4f2f-9a72-89e8f93d2276; verify claim-level fit before promotion.",
      "source": "Mov Disord",
      "strength": "medium",
      "evidence_type": "counter_evidence"
    },
    {
      "url": "https://pubmed.ncbi.nlm.nih.gov/33362788/",
      "pmid": "33362788",
      "year": "2020",
      "claim": "Gut-inflammasome links are framed as axis-level physiology and pathology, but do not prove that bacterial inflammasome priming is the dominant driver of dopaminergic vulnerability.",
      "title": "The Gut-Brain Axis: How Microbiota and Host Inflammasome Influence Brain Physiology and Pathology.",
      "caveat": "Counter-evidence curated for task 9df1f940-93f3-4f2f-9a72-89e8f93d2276; verify claim-level fit before promotion.",
      "source": "Front Immunol",
      "strength": "medium",
      "evidence_type": "counter_evidence"
    }
  ],
  "market_price": 0.853
}